Anagen Effluvium in Association With Extracorporeal Membrane Oxygenation.
Citation: Pediatric Dermatology. 34(4):e201-e202, 2017 Jul.PMID: 28612487Institution: MedStar Washington Hospital CenterDepartment: DermatologyForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: *Alopecia/et [Etiology] | *Extracorporeal Membrane Oxygenation/ae [Adverse Effects] | *Reperfusion Injury/co [Complications] | Child, Preschool | Hair Follicle/pa [Pathology] | Humans | Hypotension/co [Complications] | Hypoxia/co [Complications] | MaleYear: 2017ISSN:- 0736-8046
- Cheng, Kyle:
- http://orcid.org/0000-0003-1237-1987
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 28612487 | Available | 28612487 |
Anagen effluvium (AE) is a type of alopecia with hair loss during the growth phase of a hair follicle and is most often associated with cytotoxic chemotherapy. This report describes a case of AE in a critically ill 2-year-old boy who developed cardiorespiratory failure requiring extracorporeal membranous oxygenation. We postulate that the combination of hypotension and hypoxia with subsequent reperfusion triggered an apoptotic cascade in the hair matrix, resulting in AE.
Copyright � 2017 Wiley Periodicals, Inc.
English